These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3322271)

  • 1. Glucagon- and insulin degradation by hemolysate of human erythrocytes.
    Hildebrandt W; Kohnert KD; Blech W
    Biomed Biochim Acta; 1987; 46(7):557-63. PubMed ID: 3322271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteolytic degradation of glucagon by human erythrocytes].
    Hildebrandt W; Wiederanders B; Brömme HJ; Blech W
    Biomed Biochim Acta; 1985; 44(11-12):1599-608. PubMed ID: 3911953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin and glucagon degrading proteinase of rat liver. Separation of the proteinase from the thiol-proteindisulfide oxidoreductases.
    Ansorge S; Bohley P; Kirschke H; Langner J; Wiederanders B
    Biomed Biochim Acta; 1984; 43(1):29-38. PubMed ID: 6372796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin and glucagon degrading proteinase of rat liver: a metal-dependent enzyme.
    Ansorge S; Bohley P; Kirschke H; Langner J; Wiederanders B
    Biomed Biochim Acta; 1984; 43(1):39-46. PubMed ID: 6372797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin-like substance and insulin-degrading complex in hemolysates of human erythrocytes].
    Matuliavichius VA; Vareĭkis EI; Lashas LV
    Biokhimiia; 1986 Feb; 51(2):278-84. PubMed ID: 3516229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of thiol-protein disulfide oxidoreductase, insulin-glucagon proteinase and cathepsin D in different cell types of the rat liver.
    Ansorge S; Wiederanders B; Riemann S; Brouwer A; Knook DL
    Biomed Biochim Acta; 1984; 43(11):1213-21. PubMed ID: 6442577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucagon degradation in the in vitro recycling perfused rat liver during acute energy deficiency].
    Hildebrandt W; Brömme HJ; Kohnert KD; Blech W
    Biomed Biochim Acta; 1989; 48(4):211-9. PubMed ID: 2665736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Degradation and association of glucagon by intact human erythrocytes].
    Hildebrandt W; Dudek S; Blech W
    Biomed Biochim Acta; 1989; 48(8):509-15. PubMed ID: 2619724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin degradation in human erythrocyte. Effects of reduced glutathione on insulin degradation by hemolysate.
    Bellomo G; Nicotera PL; Fratino P
    Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1660-5. PubMed ID: 7030365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiol-protein disulfide oxidoreductase and peptidase activities in insulinoma tissue.
    Kohnert KD; Hehmke B; Woltanski KP; Ulrich FE; Zühlke H
    Biomed Biochim Acta; 1983; 42(9):1091-101. PubMed ID: 6322744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin-degrading complex of the hemolysate from human erythrocytes].
    Matuliavichius VA; Vareĭkis EI; Lashas LV; Pankov IuA
    Dokl Akad Nauk SSSR; 1984; 279(1):237-40. PubMed ID: 6394253
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin binding to erythrocytes incubated in vitro at physiological temperature.
    Freidenberg GF; Kao M; Olefsky JM
    J Clin Endocrinol Metab; 1983 Jul; 57(1):107-14. PubMed ID: 6343415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin degradation in hepatocytes and erythrocytes of rats in normal condition and in experimental diabetes].
    Nikolaev SL; Strelkova MA; Komov VP
    Vopr Med Khim; 2001; 47(3):329-37. PubMed ID: 11558315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Critical assessment of the methods of binding and degradation studies in modern hormone research exemplified by the study of glucagon metabolism of human erythrocytes and rat hepatocytes].
    Hildebrandt W; Dudek S; Brömme HJ
    Z Med Lab Diagn; 1987; 28(4):191-8. PubMed ID: 3307197
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding and degradation of 125I-insulin in human erythrocytes. Comparative studies with hemolysate and membranes.
    Bellomo G; Bellazzi R; Nicotera PL; Francesconi R; Fratino P
    J Endocrinol Invest; 1982; 5(5):287-91. PubMed ID: 6759565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D activity protects against development of type AA amyloid fibrils.
    van der Hilst JC; Kluve-Beckerman B; van der Meer JW; Simon A
    Eur J Clin Invest; 2009 May; 39(5):412-6. PubMed ID: 19740371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin degradation by human erythrocyte lysates.
    Nerurkar SG; Gambhir KK
    Clin Chem; 1981 Apr; 27(4):607-9. PubMed ID: 7008973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium influx: a possible role for insulin modulation of intracellular distribution and activity of 6-phosphofructo-1-kinase in human erythrocytes.
    Zancan P; Sola-Penna M
    Mol Genet Metab; 2005 Nov; 86(3):392-400. PubMed ID: 16122962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.